| Time | Opening Ceremony |
|---|---|
| 14:00 | Opening Ceremony |
| Time | Peritoneal Pathophysiology |
|---|---|
| 14:00-15:15 | Moderators |
| 14:00-14:15 | Surgical Anatomy of the Peritoneum |
| 14:20-14:35 | Pathophysiology of Peritoneal Carcinomatosis |
| 14:40-14:55 | The Rationale for Intraperitoneal Chemotherapy in Peritoneal Surface Malignancies |
| 15:00-15:15 | International PSOGI Consensus on Hyperthermic Intraperitoneal Chemotherapy (HIPEC) |
| 15:15-15:30 | Coffee Break |
| Time | Patient Management |
|---|---|
| 15:45-17:00 | Moderators |
| 15:45-16:00 | Patient Selection for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) |
| 16:05-16:20 | How to Initiate CRS and HIPEC Programs? |
| 16:25-16:40 | Anesthetic and Intensive Care Management in Cytoreductive Surgery (CRS) and HIPEC |
| Session Chairs | Nursing Session |
| 16:45-17:00 | Preoperative Nursing Management in CRS and HIPEC |
| 17:00-17:30 | Coffee Break |
| Time | Patient Management |
|---|---|
| 17:30-18:30 | Moderators |
| 17:30-17:45 | Preoperative and Postoperative Radiological Imaging |
| 17:50-18:05 | Nutrition in Peritoneal Carcinomatosis |
| Session Chairs | Nursing Session |
| 18:10-18:30 | Nursing Care in Perioperative Patient Management |
| Time | CRS–HIPEC Through the Eyes of Its Architect |
|---|---|
| 18:45-19:05 | The History of CRS and HIPEC - Paul SUGARBAKER |
| 19:10-19:30 | The Role of NIPS in Gastric Cancer Treatment - Paul SUGARBAKER |
| Time | Organ-Specific Cytoreductive Surgery (CRS) and HIPEC |
|---|---|
| 09:00-10:15 | Moderators |
| 09:00-09:15 | Effectiveness of Cytoreductive Surgery (CRS) and HIPEC in Gastric Cancer - Beate RAU |
| 09:20-09:35 | Oncologic Perspective on Peritoneal Metastatic Gastric Cancer |
| 09:40-09:55 | Effectiveness of Cytoreductive Surgery (CRS) and HIPEC in Colorectal Cancer |
| 10:00-10:15 | Oncologic Perspective on Peritoneal Metastatic Colorectal Cancer |
| 10:15-10:30 | Coffee Break |
| Time | Organ-Specific CRS + HIPEC |
|---|---|
| 10:30-12:05 | Moderators |
| 10:30-10:45 | Effectiveness of Cytoreductive Surgery (CRS) and HIPEC in Pseudomyxoma Peritonei - Faheez MOHAMED |
| 10:50-11:05 | Effectiveness of Cytoreductive Surgery (CRS) and HIPEC in Ovarian Cancer |
| 11:10-11:25 | Oncologic Perspective on Peritoneal Metastatic Ovarian Cancer |
| 11:30-11:45 | Effectiveness of Cytoreductive Surgery (CRS) and HIPEC in Peritoneal Mesothelioma |
| 11:50-12:05 | An Oncologist’s Perspective on Peritoneal Mesothelioma |
| 12:05-13:05 | Lunch Break |
| Time | Surgical Techniques in Cytoreductive Surgery (CRS) |
|---|---|
| 13:05-14:20 | Moderators |
| 13:05-13:20 | Right Upper Quadrant (RUQ) - Beate RAU |
| 13:25-13:40 | Left Upper Quadrant (RUQ) - Faheez MOHAMED |
| 13:45-14:00 | Pelvis |
| Session Chairs | Nursing Session |
| 14:05-14:20 | Nursing in Postoperative Patient Follow-up |
| 14:20-14:35 | Coffee Break |
| Time | Introduction to PIPAC |
|---|---|
| 14:35-15:30 | Moderators |
| 14:35-14:50 | PIPAC: How I Perform the Procedure |
| 14:55-15:10 | Indications and Contraindications for PIPAC |
| Session Chairs | Nursing Session |
| 15:15-15:30 | Nursing Practice in PIPAC Administration |
| 09:00 - 16:00 | Fresh-Frozen Cadaver Training in CRS, HIPEC and PIPAC Procedures | |
|---|---|---|
| Cadaver 1 | ||
![]() | Mentor 1: Beate Rau, Charité – Universitätsmedizin Berlin | |
![]() | 1- Ozan Verendağ, Tepecik Training and Research Hospital, Department of General Surgery / İzmir | |
![]() | 2- Ebubekir Korucuk, Erciş State Hospital, Department of General Surgery / Van | |
![]() | 3- Özgün Cevdet Köse, Harakani State Hospital, Department of General Surgery / Kars | |
![]() | 4- Yunus Emre Aktimur, Yozgat City Hospital, Department of General Surgery / Yozgat | |
| Cadaver 2 | ||
![]() | Mentor 1: Faheez MOHAMED, The Hampshire Clinic in Basingstoke Mentor 2: | |
![]() | 1- Vüsela Mededova, MD. PhD. Gynecologic Oncologist, DTX Hospital, Baku | |
| Cadaver 3 | ||
| Mentor 1: Mentor 2: | ||
| Cadaver 4 | ||
| Mentor 1: Mentor 2: | ||
| Location | Department of Anatomy, Faculty of Medicine, Ege University | |